E

Euroapi SAS
PAR:EAPI

Watchlist Manager
Euroapi SAS
PAR:EAPI
Watchlist
Price: 2.158 EUR -3.23% Market Closed
Market Cap: 206.3m EUR

Relative Value

The Relative Value of one EAPI stock under the Base Case scenario is hidden EUR. Compared to the current market price of 2.158 EUR, Euroapi SAS is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EAPI Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
80
vs Industry
88
Median 3Y
0.4
Median 5Y
0.3
Industry
2.6
Forward
0.2
vs History
vs Industry
37
Median 3Y
-2
Median 5Y
-2.2
Industry
21.7
Forward
-15.4
vs History
64
vs Industry
52
Median 3Y
4.4
Median 5Y
4.2
Industry
16.7
vs History
vs Industry
25
Median 3Y
-1.6
Median 5Y
-1.8
Industry
23.1
vs History
93
vs Industry
79
Median 3Y
0.4
Median 5Y
0.4
Industry
2.2
vs History
80
vs Industry
89
Median 3Y
0.6
Median 5Y
0.5
Industry
2.9
Forward
0.2
vs History
73
vs Industry
73
Median 3Y
3.3
Median 5Y
2.8
Industry
5.5
vs History
51
vs Industry
49
Median 3Y
4
Median 5Y
3.7
Industry
13.2
Forward
2.9
vs History
vs Industry
3
Median 3Y
40.1
Median 5Y
38.2
Industry
16.8
Forward
-4.3
vs History
66
vs Industry
52
Median 3Y
5
Median 5Y
4.7
Industry
15.9
vs History
vs Industry
25
Median 3Y
-8.6
Median 5Y
-11.9
Industry
19.2
vs History
93
vs Industry
82
Median 3Y
0.4
Median 5Y
0.4
Industry
1.9

Multiples Across Competitors

EAPI Competitors Multiples
Euroapi SAS Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Euroapi SAS
PAR:EAPI
205m EUR 0.2 -1.6 3.6 -12.1
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.1 55.3 37.1 39.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
496.3B USD 5.4 19.8 16.2 21
CH
Roche Holding AG
SIX:ROG
262.9B CHF 4.3 27.9 11.9 13.9
UK
AstraZeneca PLC
LSE:AZN
212.8B GBP 4.9 30.5 109.1 159.7
CH
Novartis AG
SIX:NOVN
212.1B CHF 4.8 18.6 11.8 15.2
US
Merck & Co Inc
NYSE:MRK
260.5B USD 4.1 13.7 9.7 11.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.7 14.2 9.9 11.6
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
143B USD 2.3 14.6 7.4 10.1
P/E Multiple
Earnings Growth PEG
FR
E
Euroapi SAS
PAR:EAPI
Average P/E: 24.3
Negative Multiple: -1.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.3
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.9
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.5
38%
0.8
CH
Novartis AG
SIX:NOVN
18.6
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.7
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14.2
4%
3.6
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
E
Euroapi SAS
PAR:EAPI
Average EV/EBITDA: 399.5
3.6
21%
0.2
US
Eli Lilly and Co
NYSE:LLY
37.1
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.9
4%
3
UK
AstraZeneca PLC
LSE:AZN
109.1
10%
10.9
CH
Novartis AG
SIX:NOVN
11.8
6%
2
US
Merck & Co Inc
NYSE:MRK
9.7
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.9
2%
5
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
E
Euroapi SAS
PAR:EAPI
Average EV/EBIT: 1 881.5
Negative Multiple: -12.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.8
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.9
5%
2.8
UK
AstraZeneca PLC
LSE:AZN
159.7
23%
6.9
CH
Novartis AG
SIX:NOVN
15.2
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.5
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11.6
1%
11.6
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
8%
1.3